Chemoinformaics analysis of 2,6-Diisopropylnaphthalene
| Molecular Weight | 212.336 | nRot | 2 |
| Heavy Atom Molecular Weight | 192.176 | nRig | 11 |
| Exact Molecular Weight | 212.156 | nRing | 2 |
| Solubility: LogS | -6.5 | nHRing | 0 |
| Solubility: LogP | 5.682 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 2 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
| nHA | 0 | APOL | 40.0559 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.65 |
| Synth | 1.73 |
| Natural Product Likeliness | -0.135 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.415 |
| Pgp-sub | 0.028 |
| HIA | 0.006 |
| CACO-2 | -4.608 |
| MDCK | 0.0000109 |
| BBB | 0.344 |
| PPB | 0.980651 |
| VDSS | 1.752 |
| FU | 0.0237329 |
| CYP1A2-inh | 0.861 |
| CYP1A2-sub | 0.877 |
| CYP2c19-inh | 0.552 |
| CYP2c19-sub | 0.497 |
| CYP2c9-inh | 0.411 |
| CYP2c9-sub | 0.726 |
| CYP2d6-inh | 0.841 |
| CYP2d6-sub | 0.562 |
| CYP3a4-inh | 0.328 |
| CYP3a4-sub | 0.54 |
| CL | 4.386 |
| T12 | 0.08 |
| hERG | 0.033 |
| Ames | 0.066 |
| ROA | 0.242 |
| SkinSen | 0.231 |
| Carcinogencity | 0.306 |
| EI | 0.987 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.640138 |